Mirati Therapeutics, Inc. (MRTX) Social Stream



Mirati Therapeutics, Inc. (MRTX): $39.10

0.33 (+0.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 382

in industry

MIRATI THERAPEUTICS INC (MRTX) Price Targets From Analysts

Use the tables below to see what analysts covering MIRATI THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 11 $235 $171 $198.857 $41.4 380.33%
2021-11-16 10 $235 $171 $197 $41.4 375.85%
2021-11-19 11 $235 $171 $195.75 $41.4 372.83%
2022-01-31 10 $235 $171 $195.75 $41.4 372.83%
2022-02-01 9 $235 $141 $188.875 $41.4 356.22%
2022-02-16 10 $219 $141 $173.125 $41.4 318.18%
2022-02-17 10 $219 $121 $159.75 $41.4 285.87%
2022-03-01 10 $203 $117 $148.25 $41.4 258.09%
2022-04-28 10 $203 $117 $147.125 $41.4 255.37%
2022-05-04 10 $203 $99 $138.75 $41.4 235.14%
2022-05-06 10 $208 $99 $138.444 $41.4 234.41%
2022-05-12 10 $208 $99 $140.444 $41.4 239.24%
2022-05-20 11 $208 $99 $137.9 $41.4 233.09%
2022-05-26 12 $216 $99 $145 $41.4 250.24%
2022-06-01 12 $216 $82 $136.09 $41.4 228.72%
2022-06-07 11 $208 $72 $128.083 $41.4 209.38%
2022-07-27 12 $188 $72 $121.916 $41.4 194.48%
2022-08-04 12 $188 $79 $120.916 $41.4 192.07%
2022-08-08 13 $188 $85 $124.636 $41.4 201.05%
2022-08-18 13 $188 $85 $123.333 $41.4 197.91%
2022-09-17 14 $188 $85 $122.538 $41.4 195.99%
2022-10-12 14 $188 $85 $121.384 $41.4 193.2%
2022-10-14 14 $188 $85 $121.307 $41.4 193.01%
2022-11-09 15 $188 $72 $117.785 $41.4 184.5%
2022-11-16 15 $188 $72 $116.357 $41.4 181.06%
2022-11-30 14 $188 $72 $111.692 $41.4 169.79%
2022-12-09 15 $188 $52 $88.357 $41.4 113.42%
2022-12-12 15 $188 $52 $86 $41.4 107.73%
2022-12-13 16 $188 $52 $85.285 $41.4 106%
2022-12-14 16 $188 $52 $83.714 $41.4 102.21%
2023-01-23 16 $188 $53 $84.4 $41.4 103.86%
2023-01-26 16 $188 $53 $81.4 $41.4 96.62%
2023-02-08 16 $188 $50 $80.733 $41.4 95.01%
2023-03-01 15 $188 $50 $80.733 $41.4 95.01%

The Trend in the Analyst Price Target


Over the past 28 weeks, MRTX's average price target has gone down $42.6.

MRTX reports an average of 89.87% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-27 12 216 82 136.090 39.81 241.85%
2022-08-18 13 188 85 123.333 79.08 55.96%
2022-09-26 14 188 85 121.384 67.24 80.52%
2022-11-16 15 188 72 116.357 72.33 60.87%
2023-01-26 16 188 53 81.400 51.06 59.42%

MRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 8 0 8 0 0 16

The Trend in the Broker Recommendations


Over the past 13 months, MRTX's average broker recommendation rating worsened by 0.4.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how MIRATI THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3953.03% of that group.
  • MRTX has a greater average analyst price target than 4231.04% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, MIRATI THERAPEUTICS INC's number of analysts covering the stock is higher than 3984.87% of them.
  • MIRATI THERAPEUTICS INC's variance in analysts' estimates is lower than -3684.8% of stocks in the large market cap category.

In the Pharmaceutical Products industry, ZTS, ALKS, and HZNP are the three stocks most similar to MIRATI THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is MRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6862 seconds.